chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drugs details was reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Product administration error; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Product administration error) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Product administration error). At the time of the report, PRODUCT ADMINISTRATION ERROR (Product administration error) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Terrible reaction to first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced VACCINATION COMPLICATION (Terrible reaction to first shot). At the time of the report, VACCINATION COMPLICATION (Terrible reaction to first shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant product use was reported. No treatment information was provided. Reporter did not allow further contact.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster, Skin burning sensation
Clinical narrative: Shingles; Felling of burning skin on a spot in my back; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and SKIN BURNING SENSATION (Felling of burning skin on a spot in my back) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles) and SKIN BURNING SENSATION (Felling of burning skin on a spot in my back). At the time of the report, HERPES ZOSTER (Shingles) and SKIN BURNING SENSATION (Felling of burning skin on a spot in my back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Second vaccine administered from vial stored in the refrigerator for 35days/pT WAS INJECTED WITH A VIAL OVER 30 DAYS OLD; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Second vaccine administered from vial stored in the refrigerator for 35days/pT WAS INJECTED WITH A VIAL OVER 30 DAYS OLD) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Second vaccine administered from vial stored in the refrigerator for 35days/pT WAS INJECTED WITH A VIAL OVER 30 DAYS OLD). At the time of the report, PRODUCT ADMINISTRATION ERROR (Second vaccine administered from vial stored in the refrigerator for 35days/pT WAS INJECTED WITH A VIAL OVER 30 DAYS OLD) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Nurse states the patient came in for 2nd dose of Moderna vaccine on  04JUN2021.  The vial used had been in the refrigerator for 35 days. Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.   Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information was Received on 04-JUN-2021 contains No New Information On 07-Jun-2021: Follow-up information was Received won 07-JUN-2021 contains No New Information
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: I feel headache; body ache; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (I feel headache), MYALGIA (body ache) and PYREXIA (fever) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (I feel headache), MYALGIA (body ache) and PYREXIA (fever). At the time of the report, HEADACHE (I feel headache), MYALGIA (body ache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was reported No treatment information was provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site rash, Vaccination site swelling
Clinical narrative: itching; rash around injection site; injection site was red; swollen injection site; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itching), VACCINATION SITE RASH (rash around injection site), VACCINATION SITE ERYTHEMA (injection site was red) and VACCINATION SITE SWELLING (swollen injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical history was reported.  Concomitant products included FLUTICASONE PROPIONATE (FLOVENT HFA) and FORMOTEROL FUMARATE, GLYCOPYRRONIUM BROMIDE (BEVESPI AEROSPHERE) for an unknown indication.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site was red) and VACCINATION SITE SWELLING (swollen injection site). On 04-Jun-2021, the patient experienced PRURITUS (itching) and VACCINATION SITE RASH (rash around injection site). At the time of the report, PRURITUS (itching) and VACCINATION SITE RASH (rash around injection site) had not resolved and VACCINATION SITE ERYTHEMA (injection site was red) and VACCINATION SITE SWELLING (swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Back pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back pain). At the time of the report, BACK PAIN (Back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was reported No treatment information was provided   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Ear discomfort, Faeces soft, Feeling abnormal
Clinical narrative: Head cold; Scratchy throat; Sneezing; Runny nose; Soft stools; Stuffy head; blowing nose; Kind of Foggy/Fuzzy; Achy; cheeks would ache my ears would feel achy; Headache; Chills that did not last long; Low grade fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and FAECES SOFT (Soft stools) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A/OJ4C1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) Low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not reported. Treatment  information also include Neti pot.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow up information received on 01-jul-2021 contains significant follow up.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Myalgia, Nasal congestion, Nasopharyngitis
Clinical narrative: Head cold; Scratchy throat; Sneezing; Runny nose; Soft stools; Stuffy head; blowing nose; Kind of Foggy/Fuzzy; Achy; cheeks would ache my ears would feel achy; Headache; Chills that did not last long; Low grade fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and FAECES SOFT (Soft stools) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A/OJ4C1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) Low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not reported. Treatment  information also include Neti pot.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow up information received on 01-jul-2021 contains significant follow up.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rhinorrhoea, Sneezing, Throat irritation
Clinical narrative: Head cold; Scratchy throat; Sneezing; Runny nose; Soft stools; Stuffy head; blowing nose; Kind of Foggy/Fuzzy; Achy; cheeks would ache my ears would feel achy; Headache; Chills that did not last long; Low grade fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and FAECES SOFT (Soft stools) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A/OJ4C1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) Low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not reported. Treatment  information also include Neti pot.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow up information received on 01-jul-2021 contains significant follow up.
Sex: U
Vaccine: COVID19
Symptoms: Pneumonitis
Clinical narrative: inflammatory issue in lower lungs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONITIS (inflammatory issue in lower lungs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lung inflammation (Inflammatory issue in my lower lungs). Concomitant products included PREDNISONE for Lung inflammation.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PNEUMONITIS (inflammatory issue in lower lungs). At the time of the report, PNEUMONITIS (inflammatory issue in lower lungs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-May-2021 and was forwarded to Moderna on 04-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONITIS (inflammatory issue in lower lungs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lung inflammation (Inflammatory issue in my lower lungs). Concomitant products included PREDNISONE for Lung inflammation.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PNEUMONITIS (inflammatory issue in lower lungs). At the time of the report, PNEUMONITIS (inflammatory issue in lower lungs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information for the event was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: was not able to take the second dose of the Moderna vaccine as scheduled; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (was not able to take the second dose of the Moderna vaccine as scheduled) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (was not able to take the second dose of the Moderna vaccine as scheduled). At the time of the report, PRODUCT DOSE OMISSION ISSUE (was not able to take the second dose of the Moderna vaccine as scheduled) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Illness, SARS-CoV-2 test
Clinical narrative: She got covid two weeks after receiving this vaccine; Quite ill with it; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (She got covid two weeks after receiving this vaccine) and ILLNESS (Quite ill with it) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (She got covid two weeks after receiving this vaccine) and ILLNESS (Quite ill with it). At the time of the report, COVID-19 (She got covid two weeks after receiving this vaccine) and ILLNESS (Quite ill with it) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative) Tested for Covid before and was negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Decreased appetite, Dizziness, Myalgia
Clinical narrative: GI discomfort; Loss of appetite; Dizzy; Fever; Body ache; Chills; This spontaneous case was reported by a pharmacist and describes the occurrence of ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever) and MYALGIA (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever), MYALGIA (Body ache) and CHILLS (Chills). On 19-May-2021, ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever), MYALGIA (Body ache) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: GI discomfort; Loss of appetite; Dizzy; Fever; Body ache; Chills; This spontaneous case was reported by a pharmacist and describes the occurrence of ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever) and MYALGIA (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever), MYALGIA (Body ache) and CHILLS (Chills). On 19-May-2021, ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever), MYALGIA (Body ache) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pain in extremity
Clinical narrative: Arm and back muscle spasm/pain; Arm and back muscle spasm/pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Arm and back muscle spasm/pain) and PAIN IN EXTREMITY (Arm and back muscle spasm/pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Arm and back muscle spasm/pain) and PAIN IN EXTREMITY (Arm and back muscle spasm/pain). At the time of the report, MUSCLE SPASMS (Arm and back muscle spasm/pain) and PAIN IN EXTREMITY (Arm and back muscle spasm/pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain
Clinical narrative: Sore Throat after First Dose; Achy after First Dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat after First Dose) and MYALGIA (Achy after First Dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore Throat after First Dose) and MYALGIA (Achy after First Dose). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat after First Dose) and MYALGIA (Achy after First Dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter.  Treatment information was not provided.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Leg cramps after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Leg cramps after the 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Leg cramps after the 1st dose). At the time of the report, MUSCLE SPASMS (Leg cramps after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Body aches; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). At the time of the report, MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.            No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Slight headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Slight headache). At the time of the report, HEADACHE (Slight headache) outcome was unknown.            Patient experienced mild Headache in May 2021, even 3 weeks after receiving the second dose of vaccine. No concomitant and treatment medication information was reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: her arm has a little sore; rash at the back of her neck but it's not itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm has a little sore) and RASH (rash at the back of her neck but it's not itchy) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Aspirin) and Drug allergy (Codeine). Concomitant products included LEVOTHYROXINE SODIUM, AMLODIPINE BESYLATE;BENAZEPRIL and CLONIDINE for an unknown indication.    On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced PAIN IN EXTREMITY (her arm has a little sore) and RASH (rash at the back of her neck but it's not itchy). At the time of the report, PAIN IN EXTREMITY (her arm has a little sore) and RASH (rash at the back of her neck but it's not itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: hairloss; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (hairloss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced ALOPECIA (hairloss). At the time of the report, ALOPECIA (hairloss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products were not provided. Treatment products were not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blood test, Chills
Clinical narrative: Stomach problems; Long term chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach problems) and CHILLS (Long term chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Cholesterol, Arthritis and Migraine. Concomitant products included DICLOFENAC SODIUM, MISOPROSTOL (DICLOFENAC/MISOPROSTOL) for Arthritis, EVOLOCUMAB (REPATHA) for Cholesterol, CODEINE PHOSPHATE, PARACETAMOL, SALICYLAMIDE (FIORINAL [CODEINE PHOSPHATE;PARACETAMOL;SALICYLAMIDE]) for Migraine, ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE (PROZAC), MONTELUKAST SODIUM (SINGULAIR), LEVOTHYROXINE SODIUM (SYNTHROID), TRAZODONE, EZETIMIBE (ZETIA), SUMATRIPTAN and ESTRADIOL (ESTRACE VAGINAL) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Stomach problems) and CHILLS (Long term chills). At the time of the report, ABDOMINAL DISCOMFORT (Stomach problems) and CHILLS (Long term chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: other (normal) Blood test came back normal.         Concomitant products includes Pro Air inhaler, Advair generic.  Reaction/event as reported was chronic, recurrent.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Around injection site is red; Around injection site is puffy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Around injection site is red) and VACCINATION SITE SWELLING (Around injection site is puffy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Around injection site is red) and VACCINATION SITE SWELLING (Around injection site is puffy). At the time of the report, VACCINATION SITE ERYTHEMA (Around injection site is red) and VACCINATION SITE SWELLING (Around injection site is puffy) outcome was unknown.            Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Feeling jittery, Headache, Palpitations
Clinical narrative: heart palpitations; jitters; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PALPITATIONS (heart palpitations), FEELING JITTERY (jitters) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PALPITATIONS (heart palpitations), FEELING JITTERY (jitters) and HEADACHE (headache). At the time of the report, CHILLS (chills), PALPITATIONS (heart palpitations), FEELING JITTERY (jitters) and HEADACHE (headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No treatment information was provided. No relevant concomitant medications reported.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site warmth
Clinical narrative: Sore left arm; injection site was warm with firm/tight skin; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Sore left arm) and VACCINATION SITE WARMTH (injection site was warm with firm/tight skin) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     Concurrent medical conditions included Autistic disorder.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced LIMB DISCOMFORT (Sore left arm) and VACCINATION SITE WARMTH (injection site was warm with firm/tight skin). On 04-May-2021, LIMB DISCOMFORT (Sore left arm) had resolved. On 08-May-2021, VACCINATION SITE WARMTH (injection site was warm with firm/tight skin) had resolved.            Concomitant medications were not given. Treatment information were not provided.   This case was linked to MOD-2021-269192 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional events added, medical history updated
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (knee hurting so bad I can't walk) and MYALGIA (sore arm, not as bad as yesterday) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced ARTHRALGIA (knee hurting so bad I can't walk) and MYALGIA (sore arm, not as bad as yesterday). At the time of the report, ARTHRALGIA (knee hurting so bad I can't walk) and MYALGIA (sore arm, not as bad as yesterday) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. No relevant concomitant medications reported. Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up received and contains no new information.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Neck pain
Clinical narrative: pain in the midle of her neck and radiating to her right shoulder; cannot raise right arm above the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain in the midle of her neck and radiating to her right shoulder) and LIMB DISCOMFORT (cannot raise right arm above the shoulder) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced NECK PAIN (pain in the midle of her neck and radiating to her right shoulder) and LIMB DISCOMFORT (cannot raise right arm above the shoulder). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of UNK, as necessary. At the time of the report, NECK PAIN (pain in the midle of her neck and radiating to her right shoulder) and LIMB DISCOMFORT (cannot raise right arm above the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient states that the pain is intermittent, but limits her ability to raise her right arm above the level of her shoulder. When the pain returns, she cannot comb her hair or use the right hand for normal activities.  patient second dose vaccine is on 1-may-2021. No concomitant medications were mentioned.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Fatigue, Vertigo
Clinical narrative: Vertigo; worsened balance; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), BALANCE DISORDER (worsened balance) and FATIGUE (fatigue) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.   On 29-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo), BALANCE DISORDER (worsened balance) and FATIGUE (fatigue). At the time of the report, VERTIGO (Vertigo), BALANCE DISORDER (worsened balance) and FATIGUE (fatigue) had not resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Treatment to the events not provided.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Peripheral swelling
Clinical narrative: I had shortness of breath; swelling on my left foot; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (I had shortness of breath) and PERIPHERAL SWELLING (swelling on my left foot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (I had shortness of breath) and PERIPHERAL SWELLING (swelling on my left foot). At the time of the report, DYSPNOEA (I had shortness of breath) and PERIPHERAL SWELLING (swelling on my left foot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, Throat irritation
Clinical narrative: Running nose; Tickle in my throat; Slight fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Running nose), THROAT IRRITATION (Tickle in my throat) and PYREXIA (Slight fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Running nose), THROAT IRRITATION (Tickle in my throat) and PYREXIA (Slight fever). At the time of the report, RHINORRHOEA (Running nose), THROAT IRRITATION (Tickle in my throat) and PYREXIA (Slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications  were not reported  Treatment was not specified
Sex: U
Vaccine: COVID19
Symptoms: Skin mass
Clinical narrative: Lumps under my arm pits; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SKIN MASS (Lumps under my arm pits) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN MASS (Lumps under my arm pits). At the time of the report, SKIN MASS (Lumps under my arm pits) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.  No concomitant medication was provided. No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, the patient experienced HEADACHE (Severe headache). At the time of the report, HEADACHE (Severe headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No treatment information was provided. No relevant concomitant medications reported.
Sex: U
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Severe low back pain/ back pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Severe low back pain/ back pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Severe low back pain/ back pain). At the time of the report, BACK PAIN (Severe low back pain/ back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  Treatment medication was not provided by the reporter.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Fatigue, Feeling abnormal
Clinical narrative: Feeling really bad; Loss of appetize; Diarrhea; Just unable to do anything; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling really bad), DECREASED APPETITE (Loss of appetize), DIARRHOEA (Diarrhea) and FATIGUE (Just unable to do anything) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling really bad), DECREASED APPETITE (Loss of appetize), DIARRHOEA (Diarrhea) and FATIGUE (Just unable to do anything). At the time of the report, FEELING ABNORMAL (Feeling really bad), DECREASED APPETITE (Loss of appetize), DIARRHOEA (Diarrhea) and FATIGUE (Just unable to do anything) outcome was unknown.            Concomitants were not provided. No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: nose bleeds for the last 2 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleeds for the last 2 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (nose bleeds for the last 2 days). At the time of the report, EPISTAXIS (nose bleeds for the last 2 days) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.